{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:44:34Z","timestamp":1793159074672,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","award":["BT\/PR\/8064\/BID\/7\/441\/2013"],"award-info":[{"award-number":["BT\/PR\/8064\/BID\/7\/441\/2013"]}],"id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012522","name":"Central Mechanical Engineering Research Institute, Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["02(0291)17\/EMR-II"],"award-info":[{"award-number":["02(0291)17\/EMR-II"]}],"id":[{"id":"10.13039\/501100012522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bmcl.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T12:36:04Z","timestamp":1525869364000},"page":"2314-2319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells"],"prefix":"10.1016","volume":"28","author":[{"given":"Maryam","family":"Gilandoust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kachigere B.","family":"Harsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrabhavi Dhananjaya","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainiah Rushdiana","family":"Raquib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobith","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Lobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Basappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchugarakoppal S.","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.05.020_b0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","article-title":"Vascular permeability, vascular hyperpermeability and angiogenesis","volume":"11","author":"Nagy","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bmcl.2018.05.020_b0010","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2005.01361.x","article-title":"Angiogenesis: update 2005","volume":"3","author":"Dvorak","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bmcl.2018.05.020_b0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/138955711793564015","article-title":"Recent progress of small molecular VEGFR inhibitors as anticancer agents","volume":"11","author":"Xu","year":"2011","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2018.05.020_b0020","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2018.05.020_b0025","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.bmcl.2015.04.010","article-title":"Novel synthetic bisbenzimidazole that targets angiogenesis in Ehrlich ascites carcinoma bearing mice","volume":"25","author":"Roopashree","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.05.020_b0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","article-title":"Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer","volume":"31","author":"Masoumi Moghaddam","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bmcl.2018.05.020_b0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1357-2725(01)00026-7","article-title":"Structure and dual function of vascular endothelial growth factor receptor-1 Flt-1","volume":"33","author":"Shibuya","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmcl.2018.05.020_b0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independent endothelial protection of liver: role of VEGFR-1","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bmcl.2018.05.020_b0045","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1371\/journal.pmed.0040186","article-title":"Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1\/FLT1","volume":"4","author":"Lee","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.bmcl.2018.05.020_b0050","first-page":"297","article-title":"Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR\/Flk-1) in breast carcinoma","volume":"23","author":"Dales","year":"2003","journal-title":"Ann Pathol"},{"key":"10.1016\/j.bmcl.2018.05.020_b0055","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1016\/j.bmc.2015.07.069","article-title":"Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation","volume":"23","author":"Ashwini","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2018.05.020_b0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.bmcl.2009.01.046","article-title":"(1,2,3-Triazol-4-yl)benzenamines: synthesis and activity against VEGF receptors 1 and 2","volume":"19","author":"Kiselyov","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.05.020_b0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1747-0285.2007.00507.x","article-title":"1H\u20131,2,4-triazol-3-yl-anilines: novel potent inhibitors of vascular endothelial growth factor receptors 1 and 2","volume":"69","author":"Kiselyov","year":"2007","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2018.05.020_b0070","doi-asserted-by":"crossref","first-page":"14195","DOI":"10.1038\/srep14195","article-title":"Development of novel triazolo-thiadiazoles from heterogeneous \u201cGreen\u201d catalysis as protein tyrosine phosphatase 1B inhibitors","volume":"5","author":"Baburajeev","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2018.05.020_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12885-017-3214-8","article-title":"Identification of novel class of triazolo-thiadiazoles as potent inhibitors of human Heparanase and their anticancer activity","volume":"17","author":"Baburajeev","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bmcl.2018.05.020_b0080","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bmcl.2015.12.026","article-title":"Adamantyl-tethered-biphenylic compounds induce apoptosis in cancer cells by targeting Bcl homologs","volume":"26","author":"Anusha","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.05.020_b0085","doi-asserted-by":"crossref","first-page":"e0153155","DOI":"10.1371\/journal.pone.0153155","article-title":"Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K\/Akt\/mTOR signaling pathway","volume":"11","author":"Mohan","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2018.05.020_b0090","doi-asserted-by":"crossref","first-page":"e0131896","DOI":"10.1371\/journal.pone.0131896","article-title":"A one pot synthesis of novel bioactive tri-substitute-condensed-imidazopyridines that targets snake venom phospholipase A2","volume":"10","author":"Anilkumar","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2018.05.020_b0095","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.bmcl.2015.05.047","article-title":"Synthesis and characterization of novel oxazines and demonstration that they specifically target cyclooxygenase 2","volume":"25","author":"Srinivas","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.05.020_b0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/1573406411666141210141918","article-title":"Anti-cancer activity of 2,4-disubstituted thiophene derivatives: dual inhibitors of lipoxygenase and cyclooxygenase","volume":"11","author":"Rakesh","year":"2015","journal-title":"Med Chem (Shariqah (United Arab Emirates))"},{"key":"10.1016\/j.bmcl.2018.05.020_b0105","doi-asserted-by":"crossref","first-page":"x161944","DOI":"10.1107\/S2414314616019441","article-title":"5-Bromo-1,2,4-triazolo[1,5-a]pyrimidine","volume":"1","author":"Gilandoust","year":"2016","journal-title":"IUCrData"},{"key":"10.1016\/j.bmcl.2018.05.020_b0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3892\/ijo.2016.3615","article-title":"An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2\/STAT3 signaling pathway","volume":"49","author":"Sulaiman","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmcl.2018.05.020_b0115","doi-asserted-by":"crossref","first-page":"36775","DOI":"10.1039\/C6RA01906D","article-title":"Nano-cuprous oxide catalyzed one-pot synthesis of a carbazole-based STAT3 inhibitor: a facile approach via intramolecular C\u2013N bond formation reactions","volume":"6","author":"Baburajeev","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2018.05.020_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00042","article-title":"Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-\u03baB in hepatocellular carcinoma cells","volume":"8","author":"Mohan","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2018.05.020_b0125","doi-asserted-by":"crossref","first-page":"31879","DOI":"10.1074\/jbc.M114.593855","article-title":"Novel synthetic biscoumarins target tumor necrosis factor-alpha in hepatocellular carcinoma in vitro and in vivo","volume":"289","author":"Keerthy","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.05.020_b0130","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1021\/acsomega.6b00251","article-title":"Novel adamantanyl-based thiadiazolyl pyrazoles targeting EGFR in triple-negative breast cancer","volume":"1","author":"Sebastian","year":"2016","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2018.05.020_b0135","doi-asserted-by":"crossref","first-page":"34296","DOI":"10.1074\/jbc.M114.601104","article-title":"Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo","volume":"289","author":"Mohan","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.05.020_b0140","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3892\/or.2012.2045","article-title":"Role of VEGF\/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)","volume":"28","author":"Song","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmcl.2018.05.020_b0145","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2018.05.020_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(01)00518-9","article-title":"HIF-1, O2, and the 3 PHDs","volume":"107","author":"Semenza","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2018.05.020_b0155","first-page":"411","article-title":"Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt\/mTOR \/p70s6k signaling pathway","volume":"19","author":"Li","year":"2016","journal-title":"Iranian J Basic Med Sci"},{"key":"10.1016\/j.bmcl.2018.05.020_b0160","doi-asserted-by":"crossref","first-page":"a006577","DOI":"10.1101\/cshperspect.a006577","article-title":"Anti-VEGF therapies in the clinic","volume":"2","author":"Meadows","year":"2012","journal-title":"Cold Spring Harbor Perspectives Med"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18304207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18304207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:24:20Z","timestamp":1760772260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18304207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0960894X18304207"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.05.020","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}